MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers have?
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has 616 citations in the OpenAlex counts ScholarIQ stores.
When was MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers published?
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has 2011 year in the ScholarIQ index.
What is the open-access status of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers has closed oa status in the ScholarIQ index.
What is the DOI of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?
The DOI for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.
What is the PMID of MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?
The PMID for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.
What is the OpenAlex record for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers?
The OpenAlex for MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers is on the source record.